Zimmer Biomet Holdings, Inc. — Wall Street Analyst Estimates & Price Targets

ZBH

NYSEHealthcareMedical - DevicesCIK 0001136869zimmerbiomet.comAbout ZBH

Last close · Oct 16, 202694.98+0.60 (+0.64%)

Market cap$18.1B

7 firms' latest targets, last 90 days: median $104.00 ($93.00–$120.00), 9% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker

Each firm's latest target

last 90 days · 7 firms

Date	Firm	Target	Previous	Change	Vs price then	Vs price now
2026-08-10	Canaccord Genuity	$100.00	$83.00	▲ 20%	+4%	+5%
2026-08-06	Truist	$106.00	$92.00	▲ 15%	+10%	+12%
2026-08-06	Baird	$104.00	$92.00	▲ 13%	+7%	+9%
2026-08-06	UBS	$120.00	$115.00	▲ 4%	+24%	+26%
2026-08-06	Bernstein	$93.00	$99.00	▼ 6%	-5%	-2%
2026-08-06	BMO Capital	$96.00	$95.00	▲ 1%	-2%	+1%
2026-08-06	RBC Capital	$110.00	—	—	+12%	+16%

Consensus estimates

revenue and EPS by fiscal year · reported years marked

FY	Revenue	YoY	EPS	YoY	Revenue range	EPS range	Analysts
2023reported	$7.4B	+7%	$4.88	+344%	est. $7.4B+0%	est. $7.51	25
2024reported	$7.7B	+4%	$4.43	-9%	est. $7.7B+0%	est. $7.98	19
2025reported	$8.2B	+7%	$3.55	-20%	est. $8.2B+0%	est. $8.18	18
2026	$8.6B	+4%	$8.53	+4%	$8.6B–$8.6B	$8.49–$8.56	20
2027	$8.9B	+4%	$9.05	+6%	$8.8B–$9.0B	$8.83–$9.40	20
2028	$9.3B	+4%	$9.71	+7%	$9.0B–$9.4B	$8.44–$11.35	20
2029	$9.6B	+4%	$10.43	+7%	$9.5B–$9.7B	$10.28–$10.54	10
2030	$10.1B	+5%	$11.04	+6%	$10.0B–$10.2B	$10.88–$11.16	10

A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

The analysts at a glance

$104.00median target, 9% above the last close

Firms with a target · last 90 days: 7
Lowest – highest target: $93.00 – $120.00
Current grades of 16 firms: positive / neutral / negative: 4 / 10 / 2
Upgrades / downgrades · 12 months: 1 / 4
Consensus revenue growth · next 3 FY: +4% a year

Current grades

each firm's latest · 16 firms

As of	Firm	Grade
2026-08-10	Canaccord Genuity	“Hold”
2026-08-07	Truist	“Hold”
2026-08-06	Bernstein	“Market Perform”
2026-08-06	RBC Capital	“Outperform”
2026-08-06	Stifel	“Buy”
2026-07-09	BMO Capital	“Market Perform”
2026-07-06	Evercore ISI	“Outperform”
2026-05-28	Citigroup	“Neutral”
2026-04-29	Barclays	“Underweight”
2026-04-29	J.P. Morgan	“Neutral”

6 more

2026-04-29	Citizens	“Market Outperform”
2026-04-29	Wells Fargo	“Equal Weight”
2026-03-23	BTIG	“Neutral”
2026-02-10	Needham	“Hold”
2026-01-28	UBS	“Sell”
2025-12-16	Baird	“Neutral”

Grade changes

last 24 months · 6

Date	Firm	Grade
2026-07-09	BMO Capital	“Outperform” → “Market Perform” downgrade
2026-03-23	BTIG	“Buy” → “Neutral” downgrade
2026-01-05	Evercore ISI	“In Line” → “Outperform” upgrade
2025-12-16	Baird	“Outperform” → “Neutral” downgrade
2025-11-06	J.P. Morgan	“Overweight” → “Neutral” downgrade
2024-12-17	J.P. Morgan	“Neutral” → “Overweight” upgrade

54 older than 24 months

2024-07-01	Piper Sandler	“Overweight” → “Neutral” downgrade
2024-05-21	Argus Research	“Hold” → “Buy” upgrade
2024-01-04	Evercore ISI	“Outperform” → “In Line” downgrade
2023-08-28	BTIG	“Neutral” → “Buy” upgrade
2023-05-03	Bank of America	“Underperform” → “Neutral” upgrade
2023-04-11	Evercore ISI	“In Line” → “Outperform” upgrade
2023-03-31	Jefferies	“Underperform” → “Hold” upgrade
2023-03-10	Piper Sandler	“Neutral” → “Overweight” upgrade
2023-01-09	RBC Capital	“Sector Perform” → “Outperform” upgrade
2023-01-05	Raymond James	“Market Perform” → “Outperform” upgrade
2023-01-03	Evercore ISI	“Outperform” → “In Line” downgrade
2022-11-23	Wells Fargo	“Underweight” → “Equal Weight” upgrade
2022-05-27	Needham	“Buy” → “Hold” downgrade
2022-04-01	Citigroup	“Buy” → “Neutral” downgrade
2022-03-02	Loop Capital	“Buy” → “Hold” downgrade
2022-02-08	Canaccord Genuity	“Buy” → “Hold” downgrade
2022-02-02	UBS	“Buy” → “Neutral” downgrade
2022-01-19	Wells Fargo	“Overweight” → “Underweight” downgrade
2022-01-10	BTIG	“Buy” → “Neutral” downgrade
2022-01-07	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2022-01-04	Piper Sandler	“Overweight” → “Neutral” downgrade
2021-12-09	Needham	“Strong Buy” → “Buy” downgrade
2021-11-23	Argus Research	“Buy” → “Hold” downgrade
2021-04-09	Northland Capital Markets	“Market Perform” → “Outperform” upgrade
2021-01-04	Evercore ISI	“In Line” → “Outperform” upgrade
2020-04-28	Guggenheim	“Buy” → “Neutral” downgrade
2020-04-09	Evercore ISI	“Outperform” → “In Line” downgrade
2020-01-07	Piper Sandler	“Neutral” → “Overweight” upgrade
2019-12-04	Raymond James	“Outperform” → “Strong Buy” upgrade
2019-10-07	BTIG	“Neutral” → “Buy” upgrade
2019-09-18	Canaccord Genuity	“Hold” → “Buy” upgrade
2019-08-12	Argus Research	“Hold” → “Buy” upgrade
2019-07-30	Barclays	“Underweight” → “Equal Weight” upgrade
2019-07-29	Baird	“Neutral” → “Outperform” upgrade
2019-06-11	Bernstein	“Underperform” → “Market Perform” upgrade
2019-04-24	Needham	“Buy” → “Strong Buy” upgrade
2019-04-08	Evercore ISI	“In Line” → “Outperform” upgrade
2019-01-02	Citigroup	“Neutral” → “Buy” upgrade
2018-12-19	J.P. Morgan	“Overweight” → “Neutral” downgrade
2018-08-13	Needham	“Strong Buy” → “Buy” downgrade
2018-06-22	Argus	“Buy” → “Hold” downgrade
2018-05-05	Argus	“Buy” → “Hold” downgrade
2018-03-23	Baird	“Outperform” → “Neutral” downgrade
2018-01-31	Stifel	“Hold” → “Buy” upgrade
2017-12-20	Goldman Sachs	“Sell” → “Neutral” upgrade
2017-11-14	Deutsche Bank	“Hold” → “Buy” upgrade
2017-11-09	Edward Jones	“Hold” → “Buy” upgrade
2017-11-02	Piper Sandler	“Overweight” → “Neutral” downgrade
2017-07-28	Canaccord Genuity	“Buy” → “Hold” downgrade
2017-07-12	Guggenheim	“Neutral” → “Buy” upgrade
2017-04-28	Wells Fargo	“Outperform” → “Market Perform” downgrade
2016-12-15	UBS	“Neutral” → “Sell” downgrade
2016-11-08	Northcoast Research	“Buy” → “Neutral” downgrade
2016-11-01	Needham	“Buy” → “Strong Buy” upgrade

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.